- Filed
- May 30, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 30, 2025 | 130.1M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 130.1M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 130.1M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$65.99K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$82.88K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $2.78K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $3.25K |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$286.87K |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$270.65K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$165.73K |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$195.08K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $334.44K |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $320.97K |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $334.44K |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $320.97K |
| Current Assets | Q1 2025 · Mar 31, 2025 | $21.02K |
| Current Assets | Q1 2025 · Dec 31, 2024 | $22.22K |
| Total Assets | Q1 2025 · Mar 31, 2025 | $47.58K |
| Total Assets | Q1 2025 · Dec 31, 2024 | $50.32K |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | $0.00 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.00 |
| Net Income | Q1 2025 · Mar 31, 2025 | −$16.53K |
| Net Income | Q1 2025 · Mar 31, 2024 | $30.25K |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$16.54K |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $21.52K |
| Revenue | Q1 2025 · Mar 31, 2025 | $0 |
| Revenue | Q1 2025 · Mar 31, 2024 | $176.56K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $26.87K |